Non-Hodgkin's Lymphoma
clinical trial branding
Brand Concept, Marketing Materials
The Brief
Regeneron, in collaboration with Clariness, required a visual concept to support the recruitment of patients for a clinical trial investigating RGN1979, a new treatment for Non-Hodgkin’s Lymphoma (NHL). The goal was to create engaging and informative materials that would encourage healthcare professionals (HCPs) to consider the study when treating eligible patients and to motivate patients to enroll, particularly those who had relapsed after standard treatment.
The Approach
The concept centred around trees and roots. A trees life source is it’s roots, it couldn’t live without them. In the same sense the people that take part in the study are the roots and the patients in the future are the tree. They can thrive because of the strong foundations created by study participants now.
The Outcome
The final concept provided Regeneron and Clariness with a strong visual foundation for their recruitment campaign. The materials effectively conveyed the significance of the study, ensuring that both HCPs and potential participants could quickly grasp its purpose and potential benefits. By creating a professional and engaging identity, the study was positioned as a credible and essential step forward in improving NHL treatment outcomes.
